Christian Marin-Müller

CEO Speratum

(PhD, Molecular Virology and Microbiology, Baylor College of Medicine; MS, Entrepreneurial Biotechnology, Case Western Reserve University/Weatherhead School of Management; BS, Molecular Biology, Florida Tech)

Dr. Marin-Müller has worked in the field of cancer therapeutics for almost a decade, with a specific focus on the use of RNA interference technology and development of nanotechnology-based delivery of therapeutics against solid tumors.

He is co-inventor of a therapeutic miRNA treatment that can control a network of biomarkers responsible for aggressive growth and metastasis in pancreatic cancer, and has the potential to completely eliminate tumors both alone and in combination with existing modalities.

In addition to his focus on research, Dr. Marin-Müller has also been heavily involved in the biotech industry ecosystem. He has co-founded several biotechnology and service companies, and has worked as a consultant to multiple start-up and governmental organizations, contributing to the development of projects ranging from medical devices to HIV vaccine investigation.

Dr. Marin-Müller is a member of the Central American Leadership Initiative (CALI) and founding member of CR biomed, the representative entity of the biotech industry in Costa Rica.